White Paper: Combination Products: A 40 Year Regulatory Evolution
February 24, 2015
Since the first combination products came under the Food & Drug Administration’s purview over 40 years ago, the FDA has taken various actions to organize, delegate and outline how it will regulate the manufacture and distribution of these products in the U.S. This white paper from NSF discusses challenges presented by the FDA’s impending release of guidance on human factors for combination products, adverse event reporting and other documents that may impact combination products.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Opens Advanced Water Testing Laboratory in Germany
October 17, 2024European manufacturers gain a competitive edge with local NSF/ANSI/CAN 60 and 61 certification testing.
Read the Story
NSF Welcomes Mel Cash as Chief Commercial Officer
October 14, 2024Global public health and safety organisation announces new Commercial lead to drive growth and innovation.
Read the Story
NSF Spotlighted in “SDG Leaders” Series on CNBC.com
October 3, 2024The docuseries highlights businesses that are addressing core issues within the 17 United Nations (UN) Sustainable Development Goals (SDGs), offering a glimpse into what people can expect as these organisations strive to tackle existential challenges, embedding the sustainability goals at the heart of their work.
Read the Story
NSF Celebrates 80 Years of Improving Human and Planet Health
September 12, 2024NSF has been pioneering public and environmental health since 1944 by developing and implementing public and environmental health standards.
Read the Story